Two Old Meds and a DOAC a Bust in COVID-19: The ACT Trials
It's 'the end of the story for colchicine in COVID-19,' an expert said. In addition, aspirin does not help outpatients with COVID and a low-dose oral anticoagulant does not improve inpatient outcomes.